Columbus Hill Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Columbus Hill Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-666,989	Closed	-$34.7M	–	37
2018 Q4	$34.7M	Sell	666,989 -40,775	-6%	-$2.19M	6.86%	4
2018 Q3	$43.9M	Sell	707,764 -4,362	-0.6%	-$259K	2.68%	17
2018 Q2	$39.4M	Buy	712,126 +130,894	+23%	+$7.07M	2.8%	14
2018 Q1	$36.8M	Buy	581,232 +10,100	+2%	+$650K	1.61%	15
2017 Q4	$35M	Sell	571,132 -74,400	-12%	-$4.65M	2.25%	16
2017 Q3	$41.1M	Sell	645,532 -391,409	-38%	-$22.9M	2.93%	11
2017 Q2	$57.8M	Sell	1,036,941 -28,542	-3%	-$1.55M	5.81%	3
2017 Q1	$57.9M	Sell	1,065,483 -158,944	-13%	-$8.72M	2.9%	10
2016 Q4	$71.6M	Buy	1,224,427 +943,427	+336%	+$51.6M	8.08%	1
2016 Q3	$15.2M	Buy	+281,000	New	+$18.1M	1.61%	19

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Columbus Hill Capital Management's BMY Position: Q1 2019 in Review

Columbus Hill Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 666,989 shares — an estimated $34.7M sold.

Columbus Hill Capital Management first reported a position in BMY in Q3 2016 and held it in 10 quarters. The position peaked at $71.6M in Q4 2016. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

Columbus Hill Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
Columbus Hill Capital Management sold 666,989 Bristol-Myers Squibb shares in Q1 2019, an estimated $34.7M.
Columbus Hill Capital Management first reported a position in Bristol-Myers Squibb in Q3 2016 and held it in 10 quarters.
Columbus Hill Capital Management's Bristol-Myers Squibb position peaked at $71.6M in Q4 2016.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Columbus Hill Capital Management's 13F filing for Q1 2019, filed 13 May 2019.